Skoči na glavni sadržaj

Sažetak sa skupa

CARDIOEMBOLIC STROKE

Hrvoje Budinčević orcid id orcid.org/0000-0002-0184-8949 ; Klinička bolnica „Sveti Duh“, Klinika za neurologiju, Zavod za cerebrovaskularne bolesti i intenzivnu neurologiju, Zagreb, Hrvatska; Medicinski fakultet Sveučilišta J. J. Strossmayer u Osijeku, Hrvatska
Dorotea Vidaković ; Medicinski fakultet Sveučilišta J. J. Strossmayer u Osijeku, Hrvatska


Puni tekst: hrvatski pdf 411 Kb

str. 35-35

preuzimanja: 249

citiraj

Puni tekst: engleski pdf 581 Kb

str. 36-36

preuzimanja: 105

citiraj


Sažetak

Stroke is one of the leading causes of disability and mortality in the world. Cardioembolic stroke ac-counts for 30% of all ischemic strokes. Cardioembolic strokes are most commonly caused by atrial fi-brillation and are associated with increased disability, mortality and recurrence. The clinical picture of an embolic stroke is usually presented by the sudden onset of symptoms with maximal intensity, and the rapid recovery from symptoms may also indicate this type of stroke. In the secondary prevention of this type of stroke, anticoagulant therapy has a leading role. In recent years, new or direct oral antico-agulants such as dabigatran, rivaroxaban, apixaban and edoxaban have been available in the prevention of stroke caused by atrial fibrillation.

Ključne riječi

stroke; prevention; anticoagulant therapy

Hrčak ID:

232960

URI

https://hrcak.srce.hr/232960

Datum izdavanja:

31.12.2019.

Podaci na drugim jezicima: hrvatski

Posjeta: 1.102 *